Sana Biotechnology, Inc. (SANA) short interest & options flow
NASDAQSana Biotechnology heads into its August 11 earnings print as one of the most heavily shorted small-cap biotechs in the gene-therapy space, with the stock's brief recovery doing little to shake a persistently bearish positioning structure. Short sellers have not blinked. Short interest holds at 15.2% of the free float — roughly 40.4 million shares — and has crept higher over the…
- Market cap
- $739M
- Next earnings
- 10 Nov 2026
Key data as of 10 Nov 2026

SANA news and analysis
RSSNo long-form analysis yet for SANA. Pulse alerts and the live data picture are available on ORTEX.
Open SANA on ORTEX →Want the live picture for SANA?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for SANA — free to start on ORTEX.
Sign up for free →Open SANA on ORTEX